RGEN
Repligen Corporation
NASDAQ: RGEN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$113.11
-3.68% today
Updated 2026-04-29
Market cap
$6.38B
P/E ratio
131.52
P/S ratio
8.64x
EPS (TTM)
$0.86
Dividend yield
—
52W range
$110 – $176
Volume
0.9M
Repligen Corporation (RGEN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $405482.00 | $38.47M | $6.31M | $-2.45M | $3.23M | $2.31M | $13.44M | $25.93M | $18.40M | $15.05M | $7.52M | $17.45M | $32.77M | $67.22M | $62.63M | $119.02M | $172.08M | $113.92M | $175.39M | $117.42M |
| Capital expenditures | $1.33M | $1.10M | $1.34M | $597349.00 | $524666.00 | $575.46M | $1.26M | $4.63M | $5.60M | $2.63M | $4.33M | $5.45M | $14.04M | $23.15M | $26.34M | $71.28M | $133.35M | $38.99M | $32.91M | $23.52M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $524.39M | $524.39M | $823245.00 | $1.01M | $1.00M | — | $1.02M | $1.06M | $1.77M | $3.60M | $4.59M | $6.75M | $10.19M | $12.85M | $17.01M | $27.50M | $27.32M | $25.57M | $48.07M | $32.60M |
| Free cash flow | $-921047.00 | $37.36M | $4.97M | $-3.05M | $2.71M | $-573.14M | $12.18M | $21.30M | $12.80M | $12.43M | $3.20M | $12.00M | $18.73M | $44.06M | $36.28M | $47.74M | $38.74M | $74.93M | $142.49M | $93.90M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $490000.00 | — | $2.90M | $17.02M | $565.68M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $18.04M | $10.62M | $-4.47M | $18.73M | $68.14M | $51.53M | $20.06M | $343.58M | $179.88M | $-113.48M | $-74.49M | — | — | — |